News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aratana Therapeutics To Participate In Upcoming Investor Events


12/12/2013 6:21:46 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

KANSAS CITY, Kan. and BOSTON, Dec. 11, 2013 /PRNewswire/ -- Aratana Therapeutics (NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it will participate in three upcoming investor events. On Monday, December 16, 2013, the company will present at the Bank of America Merrill Lynch 2013 Animal Health Summit, as well as an investor dinner hosted by Stifel as part of its Med-Tech Madness Bus Trip. Aratana will also participate in the Guggenheim Securities Boston Healthcare Conference, to be held Tuesday, December 17, 2013.

During these events, Aratana will host one-on-one and small group meetings with investors.











Event:



Bank of America Merrill Lynch 2013 Animal Health Summit




Date:



Monday, December 16, 2013




Presentation:



8:55 am (Eastern Time)




Location:



Bank of America Merrill Lynch Conference Center; Boston, MA











Event:



Stifel Med-Tech Madness Bus Trip Dinner




Date:



Monday, December 16, 2013




Presentation:



6pm (Pacific Time)




Location:



Four Seasons Hotel; Palo Alto, CA











Event:



Guggenheim Securities Boston Healthcare Conference




Date:



Tuesday, December 17, 2013




Presentation:



n/a (1x1 meetings only)




Location:



The Langham Hotel; Boston, MA








About Aratana Therapeutics
Aratana Therapeutics is a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana's strategy is to in-license proprietary compounds from human biopharmaceutical companies and to develop these product candidates into therapeutics specifically for use in pets. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D. (investors)
jdrumm@tiberend.com; (212) 375-2664

Andrew Mielach (media)
amielach@tiberend.com; (212) 375-2694

SOURCE Aratana Therapeutics



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES